Long-Term Efficacy and Safety of Tipranavir Boosted With Ritonavir in HIV-1-Infected Patients Failing Multiple Protease Inhibitor Regimens - Concepedia

Concepedia

Publication | Closed Access

Long-Term Efficacy and Safety of Tipranavir Boosted With Ritonavir in HIV-1-Infected Patients Failing Multiple Protease Inhibitor Regimens

22

Citations

19

References

2007

Year

Martin Markowitz, Leonard N. Slater, Robert A. Schwartz, Powel Kazanjian, Bruce Hathaway, David A. Wheeler, Mitchell Goldman, Dietmar Neubacher, Douglas L. Mayers, Hernán Valdez,

JAIDS Journal of Acquired Immune Deficiency Syndromes

Abstract

TPV/r combined with other active antiretroviral agents can provide a durable treatment response for highly treatment-experienced patients.

References

	Year	Citations

Page 1